7721 - 7730 of 8666 Results
Title
Year
- Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon Activation2023OPENTitle: Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order–Disorder Transition Upon ActivationJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 167999End Page: 167999Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.jmb.2023.167999Best OA location URL: https://doi.org/10.1016/j.jmb.2023.167999Citation Count: 22
-
OPENTitle: Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteinsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00564-3Best OA location URL: https://www.nature.com/articles/s41531-023-00564-3.pdfCitation Count: 19
- LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization2025OPENTitle: LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf103Best OA location URL: https://doi.org/10.1093/braincomms/fcaf103Citation Count: 0
- TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque2013RESTRICTEDTitle: TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaqueJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 73Issue #:Start Page: 337End Page: 347Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.06.005Citation Count: 39
-
OPENTitle: LRRK2 deficiency impacts ceramide metabolism in brainJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 478Issue #: 3Start Page: 1141End Page: 1146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2016.08.082Best OA location URL: https://discovery.ucl.ac.uk/1508867/1/Plotegher.pdfCitation Count: 58
- Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-out2020OPENTitle: Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous Lrrk2 mutations and ameliorated by Lrrk2 genetic knock-outJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcz052Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcz052/33640016/fcz052.pdfCitation Count: 28
- Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome2014OPENTitle: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 2-3Start Page: 500End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201400171Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4598062Citation Count: 54
- Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank2018OPENTitle: Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think TankJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00734Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00734/pdfCitation Count: 70
- Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum2018OPENTitle: Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatumJournal Name: European Journal of NeurosciencePublisher: WileyVol: 50Issue #: 3Start Page: 2054End Page: 2064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13941Citation Count: 20
- Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases2015OPENTitle: Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 3End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13056Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13056Citation Count: 68